SPECIAL REPORT on Aducanumab Approval: Steve Pearson of ICER Discusses the Economic and Clinical Impact

Dr. Jason Crowell speaks with Dr. Steve Pearson, President of the Institute for Clinical and Economic Review, about the clinical and economic impact of aducanumab, a drug recently approved by the FDA for the treatment of Alzheimer disease.